Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC) – finals results of the phase II AVETUX trial (AIO-KRK-0216)

  • Autoren: Alexander Stein, Mascha Binder, Joseph Tintelnot, Eray Gökkurt, Sylvie Lorenzen, Jorge Riera, Reinhard Depenbusch, Thomas J. Ettrich, Steffen Dörfel, Salah-Eddin Al-Batran, Meinolf Karthaus, Uwe Pelzer, Donjete Simnica, Lisa Waberer, Axel Hinke, Carsten Bokemeyer, Susanna Hegewisch-Becker
  • Institution: Hematology-Oncology Practise Hamburg (HOPE); University Medical Center Hamburg- Eppendorf; Department of Internal Medicine IV, University Hospital Halle, Martin-Luther University Halle-Wittenberg; Rechts der Isar Hospital, Technical University of Munich; GermanyUniversity Clinics Giessen-Marburg; GermanyPrivate Practice Onkodoc GmbH Gütersloh; Center of Internal Medicine I, University of Ulm; GermanyPrivate Practice Onkozentrum Dresden; GermanyInstitute of Clinical Cancer Research, Krankenhaus Nordwest, Frankfurt; GermanyNeuperlach Clinic; Charité, Berlin; IKF Klinische Krebsforschung GmbH at Krankenhaus Nordwest, Frankfurt; CCRC, Düsseldorf
  • ASCO 2020 (Abstract)
  • DKK 2020 (Abstract + Poster)
  • Journal of Clinical Oncology 2020 (DOI: 10.1200/JCO.2020.38.4_suppl.96 Journal of Clinical Oncology 38, no. 4_suppl (February 01, 2020) 96-96.)